跳转至内容
Merck
CN

810150C

Avanti

18:1 Liss Rhod PE

Avanti Research - A Croda Brand

别名:

1,2-二油酰-sn-甘油-3-磷酸乙醇胺-N-(丽丝胺罗丹明 B 磺酰基) (铵盐)

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C68H109N4O14PS2
化学文摘社编号:
分子量:
1301.72
MDL number:
NACRES:
NA.25
UNSPSC Code:
12352211
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


assay

>99% (TLC)

form

liquid

packaging

pkg of 1 × 1 mL (810150C-1mg), pkg of 5 × 1 mL (810150C-5mg), pkg of 5 × 2 mL (810150C-10mg)

manufacturer/tradename

Avanti Research - A Croda Brand

concentration

1 mg/mL (810150C-10mg), 1 mg/mL (810150C-1mg), 1 mg/mL (810150C-5mg)

lipid type

fluorescent lipids

shipped in

dry ice

storage temp.

−20°C

General description

L-α-磷脂酰乙醇胺(PE)是动植物和酵母中含量第二高的磷脂。

Application

18:1 Liss Rhod PE适用于标记DOPC(1,2-油酰基-sn-甘油-3-磷酸胆碱)以进行成像。

Biochem/physiol Actions

18:1 Liss Rhod PE是一种荧光标记的脂质,可用于标记巨型单层囊泡(giant unilamellar vesicle,GUV)。L-α-磷脂酰乙醇胺可保持膜完整性。

Packaging

5 mL棕色玻璃螺旋盖小瓶(810150C-10mg)
5 mL棕色玻璃螺旋盖小瓶(810150C-1mg)
5 mL棕色玻璃螺旋盖小瓶(810150C-5mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC


Still not finding the right product?

Explore all of our products under 18:1 Liss Rhod PE


pictograms

Skull and crossbonesHealth hazard

signalword

Danger

Hazard Classifications

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3

target_organs

Central nervous system, Liver,Kidney

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

危险化学品
易制毒化学品(2类)

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



A new class of synthetic retinoid antibiotics effective against bacterial persisters
Kim W, et al.
Nature, 556(7699), 103-103 (2018)
Spatiotemporal control of coacervate formation within liposomes
Deshpande S, et al.
Nature Communications, 10(1), 1800-1800 (2019)
Yang Liu et al.
Nature communications, 10(1), 5108-5108 (2019-11-11)
Mounting evidence suggests that the tumor microenvironment is profoundly immunosuppressive. Thus, mitigating tumor immunosuppression is crucial for inducing sustained antitumor immunity. Whereas previous studies involved intratumoral injection, we report here an inhalable nanoparticle-immunotherapy system targeting pulmonary antigen presenting cells (APCs)



全球贸易项目编号

货号GTIN
810150C-10MG04061837666407
810150C-5MG04061837666421
810150C-1MG04061837666414